wbur.org
support wbur today!
Listen to this show
Manufacturing Depression?
photo

By guest host Jane Clayson:

Antidepressants are a multibillion dollar business in America and around the world. And therein, says psychotherapist Gary Greenberg, lies a big problem.

Pharmaceutical companies and researchers are casting their nets too wide to find new patients, calling normal, rational feelings a disease, says Greenberg. Some simple sadness, the occasional melancholy, is part of a normal life, he says, and getting rid of them may mean getting rid of the soul.

This hour On Point: manufacturing depression and the economy of melancholy.


Quotes from the Show:

“What really interested me about this experience [participating in a clinical trial study] was learning about the way that our experience of unhappiness or melancholy gets medicalized.”

“On the one hand there’re some real benefits to medicalizing suffering. … On the other hand, the cost of medicalizing depression, at least in my experience, was that the study was interested in everything except my experience.” Dr. Gary Greenburg

“The very reductionism that [Dr. Greenberg] disparages or at least critiques, is really necessary in order to make sense of the very complex data that every human brings into clinical work and clinical trials.” Dr. Jonathan Alpert

“The cost of not [medicalizing depression] is much higher.” Dr. Jonathan Alpert

“I am not against treating depression and unhappiness with drugs. … The sole question I am raising is whether their depression has to be medicalized in order to be treated.” Dr. Gary Greenburg

“Yes, I think it’s very important to distinguish illness from non-illness.” Peter Kramer

Guests:

Gary Greenberg, psychotherapist and uthor of an essay in the May issue of Harper’s Magazine called “Manufacturing Depression”;
Dr. Jonathan Alpert, Associate Director of the Depression Research Program at the Massachusetts General Hospital and Associate Professor of Psychiatry at Harvard Medical School.;
Dr. Peter Kramer, a clinical professor of psychiatry and human behavior at Brown University and author of “Against Depression,” “Listening to Prozac” and “Freud: Inventor of the Modern Mind.”

 
 

Comments are closed.

On Point Today
Hour 2
Crooked Still
Friday, July 3, 2009 image

Tunes from old Appalachia with a new bluegrass twist. The hit folk band “Crooked Still” plays for us in our studio.

Comments [5]
 
Hour 1
Week in the News
Friday, July 3, 2009 image

A U.S. offensive in Afghanistan. Al Franken heads to the Senate. Mark Sanford keeps talking. And unemployment keeps rising. Our weekly news roundtable goes behind the headlines.

Comments [16]

Recent Shows
Rick Bass and the Montana Wild
Thursday, July 2, 2009 image

Author Rick Bass walks us through the changing seasons of the Montana wilderness, in his new book, “The Wild Marsh.”

Comments [8]
 
Controlling the American Appetite
Thursday, July 2, 2009 image

Former FDA chief David Kessler took on Big Tobacco. Now he tells us how the food industry plays with our brain chemistry, and turns us into hyper-eaters.

Comments [72]
On Point Blog
India, China and the Climate

The passage of the House climate bill – discussed in our first hour today – has been greeted with enthusiasm in many quarters. But in some ways, the real question is whether a global framework can be established in Copenhagen in December, when countries will negotiate a new international treaty to curb greenhouse gases. After all, America emits only [...]

More » | Comments [1]
 
Michael, Ed, and Farrah

The week-in-the-news roundtable always involves tough choices on sound clips – what to include, what to leave out. Amid all the pressing hard news, we often give a nod to a notable person who’s passed away. But this week brought, well, a ridiculous range of choices. So we gave a nod to them all in the roundtable today. And [...]

More »
 
Planet Money, On Point — Your Questions!

On Wednesday night, June 24, On Point will tape a show before an audience in Boston with two stars of NPR’s “Planet Money,” Adam Davidson and David Kestenbaum. We need your online questions to put to them — about anything from the roots of the economic crisis to NPR’s coverage.
What’s your question about the [...]

More » | Comments [18]